Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN78348355
ISRCTN78348355
Completed
未知

A study investigating the cardioprotective benefits of remote ischaemic postconditioning in different clinical settings of myocardial ischaemia-reperfusion injury

niversity College London (UCL) (UK)0 sites500 target enrollmentJune 18, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsTopic: Cardiovascular, NeurologicalSubtopic: Cardiovascular (all Subtopics), Neurological (all Subtopics)Disease: Cardiovascular, Nervous system disordersCirculatory SystemMyocardial ischaemia-reperfusion injury

Overview

Phase
未知
Intervention
Not specified
Conditions
Topic: Cardiovascular, Neurological
Sponsor
niversity College London (UCL) (UK)
Enrollment
500
Status
Completed
Last Updated
8 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 18, 2010
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity College London (UCL) (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients undergoing percutanous coronary interventions in the elective and emergecy setting and patients undergoing thrombolysis for acute myocardial infarction
  • •2\. Aged greater than 18 years and less than 85 years
  • •3\. Male and female patients

Exclusion Criteria

  • •1\. Aged less than 18 years and greater than 85 years
  • •2\. Patients with severe renal impairment (estimated glomerular filtration rate \[EGFR] less than 45 ml/min/1\.73m2\)
  • •3\. Patients with severe hepatic impairment
  • •4\. Patients with cardiac arrest in the previous 6 weeks

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Heart protection studyCoronary heart disease (CHD)Circulatory SystemChronic ischaemic heart disease
ISRCTN48489393Medical Research Council (MRC) (UK)20,000
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes
EUCTR2015-003563-10-ROovo Nordisk A/S3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes
EUCTR2015-003563-10-ITOVO NORDISK. S.P.A.3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes
EUCTR2015-003563-10-GBovo Nordisk A/S3,183
Active, not recruiting
Phase 1
A trial investigating the cardiovascular safety of oral semaglutide in subjects with type 2 diabetes
EUCTR2015-003563-10-NLovo Nordisk A/S3,176